These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9617040)

  • 1. Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis.
    Mansy SS; Yehia HA; Hassan MM; Hassan EA; Youssef MM; Hadi AA; Mackenzie CD
    J Egypt Soc Parasitol; 1998 Apr; 28(1):23-44. PubMed ID: 9617040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of octreotide on the pathology of hepatic schistosomiasis.
    Mansy SS; Yehia HA; Hassan MM; Hassan EA; Youssef MM; Hadi AA; Mackenzie CD
    Arzneimittelforschung; 1998 Aug; 48(8):855-61. PubMed ID: 9748716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
    Morsy GH
    J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of colchicine with or without praziquantel therapy in the control of hepatic fibrosis in murine schistosomiasis.
    Badawy AA; el-Badrawy NM; Mansy SS; Akl MM; Abdel Hady AM; Ebeid FA; Hassan MM
    Pharmacol Res; 1996 Jun; 33(6):319-25. PubMed ID: 8971953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
    El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
    William S; Guirguis F; Nessim NG
    Arzneimittelforschung; 2003; 53(7):532-7. PubMed ID: 12918221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.
    Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E
    BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
    Mahmoud MR; Zoheiry MM; Nosseir MM
    Arzneimittelforschung; 2002; 52(4):294-301. PubMed ID: 12040972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
    Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
    Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis.
    Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; Megahed N
    Parasitol Int; 2017 Oct; 66(5):545-554. PubMed ID: 28408356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni.
    El-Lakkany N; el-Din SS; Ebeid F
    Exp Parasitol; 2011 Oct; 129(2):152-7. PubMed ID: 21762692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
    Botros SS; Hammam O; Mahmoud M; Bergquist R
    APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
    Helmy MM; Mahmoud SS; Fahmy ZH
    Exp Parasitol; 2009 Aug; 122(4):310-7. PubMed ID: 19389399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.
    el-Badrawy NM; Hassanein HI; Botros SS; Nagy FM; Abdallah NM; Herbage D
    Exp Mol Pathol; 1988 Oct; 49(2):151-60. PubMed ID: 3139442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic effect of the anti-inflammatory drug diclofenac in experimental schistosomiasis mansoni.
    Nessim NG; Mahmoud S
    Int J Infect Dis; 2007 Mar; 11(2):161-5. PubMed ID: 16765078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to praziquantel in Schistosoma mansoni infected mice.
    Hegazy IH; Nassar SH; Moussa SM
    J Egypt Soc Parasitol; 1997 Aug; 27(2):397-404. PubMed ID: 9257977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice.
    Kamel G; Metwally A; Guirguis F; Nessim NG; Noseir M
    Arzneimittelforschung; 2000 Apr; 50(4):391-4. PubMed ID: 10800639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of praziquantel treatment on hepatic pathology of Schistosoma mansoni experimentally infected mice.
    Khalil HM; Bebars MA; el-Badawy NM; Abdallah HM; Khalil NM; el-Zayyat EA; el-Din Mohamed MS
    J Egypt Soc Parasitol; 1995 Apr; 25(1):269-77. PubMed ID: 7602169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.